Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Perrigo Company plc (PRGO : NYSE)

• Company Description    Perrigo Co. plc, with a diversified revenue stream, sells infant formulas for the store brand market, generic extended topical prescription (Rx) products and specialty pharmaceutical drugs. It's focusing on self-care products as part of its transformation into a self-care company from a healthcare company. The company divested its Rx segment to Altaris Capital Partners. The company completed its transformation to a consumer self-care company by reconfiguring the portfolio through the divestiture of RX business. Currently, the company has 2 reporting segments. Consumer Self Care Americas (CSCA): The segment comprises the U.S., Mexico and Canada CHC business, including OTC, contract manufacturing, infant formula and animal health categories. Consumer Self Care International?(CSCI): The segment comprises the branded consumer healthcare (BCH) segment mainly in Europe and the company's consumer-focused businesses in the UK and Australia. This segment includes UK liquids licensed products business. Number of Employees: 8,379

• Price / Volume Information    Yesterday's Closing Price: $27.27 Daily Weekly Monthly 20 Day Moving Average: 866,982 shares Shares Outstanding: 137.48 (millions) Market Capitalization: $3,749.01 (millions) Beta: 0.45 52 Week High: $30.93 52 Week Low: $23.14 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 0.07% -3.67% 12 Week 7.70% -9.41% Year To Date 6.07% -0.67%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL THE SHARP BUILDING HOGAN PLACE - DUBLIN,L2 D02 IRL ph: 353-1709-4000 fax: 269-673-9128 bradley.joseph@perrigo.com http://www.perrigo.com

• General Corporate Information    Officers Patrick Lockwood-Taylor - Chief Executive Officer and President Orlando D. Ashford - Chairman Eduardo Bezerra - Chief Financial Officer Bradley A. Alford - Director Julia Brown - Director Peer Information Perrigo Company plc (BJCT) Perrigo Company plc (CADMQ) Perrigo Company plc (APNO) Perrigo Company plc (UPDC) Perrigo Company plc (IMTIQ) Perrigo Company plc (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: G97822103 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/25 Next Expected EPS Date: 08/01/25 Share - Related Items Shares Outstanding: 137.48 Most Recent Split Date: 8.00 (2.00:1) Beta: 0.45 Market Capitalization: $3,749.01 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 4.25% Current Fiscal Quarter EPS Consensus Estimate: $0.79 Indicated Annual Dividend: $1.16 Current Fiscal Year EPS Consensus Estimate: $3.03 Payout Ratio: 0.40 Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: -0.01 Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: 05/30/2025 - $0.29 Next EPS Report Date: 08/01/25

• Fundamental Ratios P/E Current FY Estimate: 9.01 Trailing 12 Months: 9.50 PEG Ratio: - Price Ratios Price/Book: 0.85 Price/Cash Flow: 5.40 Price / Sales: 0.86 EPS Growth vs. Year Ago Period: 106.90% vs. Previous Quarter: -35.48% Sales Growth vs. Year Ago Period: -3.53% vs. Previous Quarter: -8.29% ROE 06/30/25 - - 03/31/25 - 8.93 12/31/24 - 7.82 ROA 06/30/25 - - 03/31/25 - 3.87 12/31/24 - 3.38 Current Ratio 06/30/25 - - 03/31/25 - 2.36 12/31/24 - 2.38 Quick Ratio 06/30/25 - - 03/31/25 - 1.28 12/31/24 - 1.34 Operating Margin 06/30/25 - - 03/31/25 - 9.16 12/31/24 - 8.10 Net Margin 06/30/25 - - 03/31/25 - -4.16 12/31/24 - -3.93 Pre-Tax Margin 06/30/25 - - 03/31/25 - 0.60 12/31/24 - -1.85 Book Value 06/30/25 - - 03/31/25 - 31.98 12/31/24 - 31.66 Inventory Turnover 06/30/25 - - 03/31/25 - 2.46 12/31/24 - 2.54 Debt-to-Equity 06/30/25 - - 03/31/25 - 0.82 12/31/24 - 0.83 Debt-to-Capital 06/30/25 - - 03/31/25 - 45.14 12/31/24 - 45.33

Powered by Zacks Investment Research ©